Clinical utility of a novel test for assessing cardiovascular disease risk in type 2 diabetes: a randomized controlled trial

BACKGROUND: The risk for and treatment of cardiovascular disease (CVD) in type 2 diabetes (T2DM) is often incorrect and delayed. We wished to determine if a novel test improved physicians’ ability to risk stratify, diagnose, and treat patients with T2DM. METHODS: In a 2-phase randomized controlled t...

Descripción completa

Detalles Bibliográficos
Autores principales: Peabody, John W., Paculdo, David, de Belen, Enrico, Ganesan, Divya, Cooney, Isabella, Trujillo, Nelson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339653/
https://www.ncbi.nlm.nih.gov/pubmed/37438853
http://dx.doi.org/10.1186/s13098-023-01122-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339653/
https://www.ncbi.nlm.nih.gov/pubmed/37438853
http://dx.doi.org/10.1186/s13098-023-01122-w

Ejemplares similares